Mixed Hip Arthroplasty Components Show Similar Revision Rates to Matched Systems

Navigating Component Compatibility in Total Hip Arthroplasty

Total hip arthroplasty remains the gold standard for treating end-stage hip osteoarthritis, providing reliable pain relief and restoring functional mobility [1, 2]. As the procedure is increasingly performed in younger, more active populations, the focus has shifted toward optimizing implant longevity and minimizing the risk of revision surgery [3, 4]. Surgeons frequently face complex anatomical challenges, such as secondary osteoarthritis or neuromuscular conditions, which may complicate standard implant selection [5, 6]. While industry guidelines typically advocate for manufacturer-matched components to ensure mechanical integrity, clinical necessity sometimes dictates the use of mixed-brand systems. A new population-based study now evaluates whether these off-label mixed constructs actually compromise long-term clinical outcomes or if they represent a safe alternative to traditional matched systems.

Population Characteristics and Study Design

The researchers conducted a large-scale population analysis to address the clinical uncertainty surrounding component compatibility in joint replacement. The primary aim was to compare all-cause revision rates for mixed and matched total hip arthroplasty in Ontario, Canada. To establish a robust dataset, the study identified adults undergoing primary elective total hip arthroplasty between 2012 and 2020 in Ontario, Canada. The researchers utilized administrative databases to identify the study population, which allowed for a comprehensive longitudinal view of patient outcomes across the provincial healthcare system. The final analysis included a total of 66,037 patients, providing significant statistical power to detect differences in surgical failure. Specifically, the study identified 906 patients who received mixed total hip arthroplasty implants and 65,131 patients who received matched total hip arthroplasty implants. To ensure a fair comparison, the authors employed propensity score matching (a statistical technique that balances treatment groups by matching patients with similar baseline characteristics to reduce the impact of selection bias) to adjust for confounding variables. This methodology allowed the researchers to isolate the effect of implant matching on the long-term durability of the prosthetic joint, providing a clearer picture of how these choices affect surgical success in a real-world clinical setting.

Methodological Rigor and Patient Demographics

To ensure a rigorous comparison between the 906 patients in the mixed implant group and the 65,131 patients in the matched group, the researchers employed propensity score matching. This statistical method balances patient characteristics between groups to allow for a more accurate comparison by accounting for potential confounding variables that might influence surgical outcomes. The study utilized Chi-square and Fisher exact tests to compare dichotomous outcomes (clinical results with only two possibilities, such as whether a patient required a revision or did not). For continuous outcomes, such as the specific number of days spent in the hospital, the authors used Wilcoxon rank sum tests (a non-parametric statistical test used to determine if there is a significant difference between two independent groups) to evaluate differences between the matched groups. The analysis of patient demographics and clinical settings revealed distinct patterns in how mixed components are utilized in practice. Patients who received mixed implants were more likely to be women and were more frequently treated at teaching hospitals rather than community centers. Furthermore, the study found that patients in the mixed implant group were more likely to be discharged directly home following their procedure compared to those who received matched total hip arthroplasty implants. These findings suggest that while mixing components is less common, it is often performed in academic environments and is associated with favorable immediate postoperative discharge dispositions. In terms of clinical durability and resource utilization, the researchers found no significant difference in the all-cause revision rate, with the mixed group at 1.6 percent and the matched group at 1.7 percent (P = 0.797). There were also no significant differences in the specific indications for revision surgery between the two cohorts. However, the study identified a statistically significant difference in hospital resource use. Patients in the matched group had a significantly longer mean length of hospital stay at 3.23 plus or minus 2.29 days, whereas the mixed group averaged 2.84 plus or minus 2.25 days (P < 0.001). This data suggests that mixing components does not compromise short to mid-term implant stability and may be associated with shorter inpatient stays in certain clinical contexts, perhaps reflecting the practice patterns of high-volume academic surgeons.

Clinical Outcomes and Revision Risks

Most orthopedic manufacturers specify that surgeons should utilize all components of their proprietary total hip arthroplasty system to avoid working off-label (using a medical device in a manner not specifically cleared by regulatory bodies or recommended by the manufacturer). Despite these industry recommendations, previous studies have indicated that mixing certain components from different manufacturers in total hip arthroplasty can produce results that are comparable or even superior to matched systems. In this population-based analysis, the researchers found no significant difference in the revision rate between the mixed group at 1.6 percent and the matched group at 1.7 percent (P = 0.797). Furthermore, there was no significant difference in the specific indications for revision surgery between the two cohorts, suggesting that the mechanical and biological failure modes remain consistent regardless of whether the implant system is matched or mixed. Beyond the primary outcome of implant longevity, the study identified differences in perioperative resource utilization. Patients in the matched group had a significantly longer mean length of hospital stay of 3.23 plus or minus 2.29 days, while patients in the mixed group had a significantly shorter mean length of hospital stay of 2.84 plus or minus 2.25 days (P < 0.001). This administrative data from Ontario, Canada, demonstrates that mixing total hip arthroplasty components appears to have no effect on all-cause revision when compared to matched systems. For the practicing clinician, these findings suggest that the off-label practice of mixing components does not compromise patient safety or increase the risk of surgical failure, providing evidence-based reassurance when intraoperative needs or anatomical requirements necessitate the use of non-matched implants. This may allow for greater intraoperative flexibility without the concern of predisposed mechanical failure or increased revision risk.

References

1. Za P, Casciaro C, Papalia GF, et al. Hip resurfacing versus total hip arthroplasty: a systematic review and meta-analysis of randomized clinical trials.. International orthopaedics. 2024. doi:10.1007/s00264-024-06269-3

2. Loke RWK, Lim YH, Chan YK, Tan BWL. MAKO robotic-assisted compared to conventional total hip arthroplasty for hip osteoarthritis: a systematic review and meta-analysis.. Journal of orthopaedic surgery and research. 2025. doi:10.1186/s13018-025-05866-1

3. Parsa A, George T, Bruning R, Padilla P, Schinsky MF, Domb BG. Postoperative gait parameters in hip resurfacing compared to total hip arthroplasty: a systematic review.. Hip international : the journal of clinical and experimental research on hip pathology and therapy. 2025. doi:10.1177/11207000251321765

4. Hoorntje A, Janssen KY, Bolder SBT, et al. The Effect of Total Hip Arthroplasty on Sports and Work Participation: A Systematic Review and Meta-Analysis.. Sports medicine (Auckland, N.Z.). 2018. doi:10.1007/s40279-018-0924-2

5. Larrague C, Fieiras C, Campelo D, et al. Feasibility of total hip arthroplasty in cerebral palsy patients: a systematic review on clinical outcomes and complications.. International orthopaedics. 2022. doi:10.1007/s00264-022-05528-5

6. Ilo K, Hallikeri P, Naathan H, et al. Outcomes of Primary Total Hip Arthroplasty Using Custom Femoral Stems in Patients With Secondary Hip Osteoarthritis: A Systematic Review.. Arthroplasty today. 2024. doi:10.1016/j.artd.2024.101504